CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
AMADIX focuses on developing non-invasive blood tests for early cancer detection, particularly for colon, lung, and pancreatic cancers. By leveraging advanced data analytics and artificial intelligence, the project aims to identify new risk factors and improve patient outcomes through predictive modeling and analysis o…
Founded in 2010, AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood.
The mission of the company is extending people lives, developing disruptive technologies to detect the tumor years in advance, before the symptoms appear.
The company’s products are oriented to non-invasive early cancer detection, avoiding the complications of existing invasive procedures, as tumor biopsies in colon, lung and pan…
ADVANCED MARKER DISCOVERY SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
